Please assess the completion status of the following clinical trial:

Trial Title: Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 1 diabetes for at least 12 months~* Body mass index (BMI) for children (6 to 12 years): 15-20 kg/m\^2 (both inclusive)~* Body mass index (BMI) for adolescents (13 to 17 years): 18-25 kg/m\^2 (both inclusive)~* HbA1c (glycosylated haemoglobin) below 11.0% according to central laboratory results~* Current treatment with insulin at least twice daily~Exclusion Criteria:~* Any significant disease such as endocrine, hepatic, renal, cardiac, neurological, malignant, or pancreatic disease other than diabetes~* Receipt of any investigational product within the last four weeks~* Known or suspected allergy to trial products or related products

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Insulin detemir (Type: EXPERIMENTAL): None
- Insulin glargine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).